An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe

Condition:   Primary Hypercholesterolemia Intervention:   Sponsor:   Boryung Pharmaceutical Co., Ltd Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials